Consequences of Hypoglycaemia on Cardiovascular and Inflammatory Responses

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
HypoglycemiaInflammatory ResponseDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
PROCEDURE

hyperinsulinemic normoglycaemic-hypoglycaemic glucose clamp

For this study, a hyperinsulinemic normoglycaemic-hypoglycaemic glucose clamp will be conducted to investigate the effect of hypoglycaemia. This means that subjects will receive an intravenous insulin infusion, at a continuous rate of 60 mU∙m-2∙min-1, as well as glucose 20% w/w intravenously at a variable rate, adjusted by arterial plasma glucose levels, measured at 5 minute intervals.

Trial Locations (2)

3400

Nordsjællands University Hospital, Hillerød

6525 GA

Radboudumc, Nijmegen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Radboud University Medical Center

OTHER

NCT03976271 - Consequences of Hypoglycaemia on Cardiovascular and Inflammatory Responses | Biotech Hunter | Biotech Hunter